Skip to main content
SpringerLink
Log in

Study on the Effect of Chemo-Radiation on the Serum Levels of IGF-I in Patients with Cancer Cervix Stage IIIB

  • Original Article
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

Abstract

Purpose

Insulin-like growth factor type 1 (IGF-1) plays an important role in cancer proliferation and drug resistance. There are no published data on serum IGF-1 levels and the effect of chemo-radiotherapy on IGF-1 levels in advanced cervical cancer.

Methods

The study was a prospective observational study conducted at a tertiary cancer center. It included patients diagnosed with stage IIIB cervical cancer. Patients were treated with chemo-radiotherapy. IGF-1 levels were measured at baseline, 1 month and 6 months after completion of treatment.

Results

The study included 32 patients with a median age of 42 years. All patients completed the planned treatment. The mean IGF-1 levels at baseline, 1-month and 6-month post-treatment were 168.40 ng/ml, 197.1 ng/ml and 146.51 ng/ml, respectively. The IGF-1 levels increased with treatment (P = 0.13) and then declined on follow-up (P = 0.003). IGF-1 levels did not correlate with tumor size or response to treatment.

Conclusion

Serum IGF-1 levels in advanced cervical cancer increase with chemo-radiotherapy and decline on follow-up. Further studies are required to understand the implication of this finding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Maheshwari A, Kumar N, Mahantshetty U. Gynecological cancers: a summary of published Indian data. South Asian J Cancer. 2016;5:112–20.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am. 2012;41:335–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Denduluri SK, Idowu O, Wang Z, Liao Z, Yan Z, Mohammed MK, Ye J, Wei Q, Wang J, Zhao L, Luu HH. Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance. Genes Dis. 2015;2:13–25.

    Article  CAS  PubMed  Google Scholar 

  4. Serum IGF-1 levels. Available at https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=167&contentid=insulin_like_growth_factor. Accessed 14 May 201.

  5. Mathur SP, Mathur RS, Underwood PB, Kohler MF, Creasman WT. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003;91:486–93.

    Article  CAS  PubMed  Google Scholar 

  6. Lloret M, Lara PC, Bordón E, Pinar B, Rey A, Falcón O, Molano F. Hernández MA IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy. Gynecol Oncol. 2007;106:8–11.

    Article  CAS  PubMed  Google Scholar 

  7. Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM. Serum levels of insulin-like growth factor-1 and -2 and insulin like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Biomedica. 2006;26(2):258–68.

    Article  PubMed  Google Scholar 

  8. Huang YF, Shen MR, Hsu KF, Cheng YM, Chou CY. Clinical implications of insulin-like growth factor 1 system in early stage cervical cancer. Br J Cancer. 2008;99:1096–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chanson P, Arnoux A, Mavromati M, Brailly-Tabard S, Massart C, Young J, Piketty ML, Souberbielle JC. VARIETE investigators. Reference values for IGF-I serum concentrations: comparison of six immunoassays. J Clin Endocrinol Metab. 2016;101:3450–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346–53.

    Article  CAS  PubMed  Google Scholar 

  11. Svensson J, Carlzon D, Petzold M, Karlsson MK, Ljunggren Ö, Tivesten A, Mellström D, Ohlsson C. Both low and high serum IGF-I levels associate with cancer mortality in older men. J Clin Endocrinol Metab. 2012;97:4623–30.

    Article  CAS  PubMed  Google Scholar 

  12. Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, Kenfield SA, Stampfer MJ, Giovannucci EL. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer. 2015;136:2418–26.

    Article  CAS  PubMed  Google Scholar 

  13. Durzyńska J. IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review). Oncol Rep. 2014;32:2295–306.

    PubMed  PubMed Central  Google Scholar 

  14. Heidegger I, Massoner P, Sampson N, Klocker H. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer. Cancer Lett. 2015;367:113–21.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, Cancer Institute (WIA), Adyar, Chennai, 600020, India

    Priya Iyer

  2. Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, India

    Venkatraman Radhakrishnan

  3. Department of Radiotherapy, GCRI, Ahmedabad, India

    Rakesh Vyas

  4. Receptor Growth Factor Laboratory, GCRI, Ahmedabad, India

    Sunil Trivedi

Authors
  1. Priya Iyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Venkatraman Radhakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rakesh Vyas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sunil Trivedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Priya Iyer.

Ethics declarations

Funding

The study was funded by Gujarat Cancer Research Institute.

Conflict of interest

None of the authors have any conflict of interest.

Ethical Approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iyer, P., Radhakrishnan, V., Vyas, R. et al. Study on the Effect of Chemo-Radiation on the Serum Levels of IGF-I in Patients with Cancer Cervix Stage IIIB. Indian J Gynecol Oncolog 15, 34 (2017). https://doi.org/10.1007/s40944-017-0127-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-017-0127-z

Keywords

Search

Navigation